$PPHM Recent Headlines Apollo slammed on education

New Post Public Reply Private Reply Replies (0) Message Board

Oct 16, 2014 at 11:57 AM

$PPHM Recent Headlines

Apollo slammed on education department review 6:09 p.m. July 14, 2014 - Tom Bemis
Peregrine plunges on test data 4:17 p.m. June 27, 2013 - Russ Britt
Small-cap makes a splash with FDA nod for cancer drug 3:16 p.m. May 20, 2013 - Russ Britt
Peregrine drug shows promise in pancreatic cancer 1:17 p.m. Feb. 13, 2013 - MarketWatch.com
In focus: Bullish, but overbought 8:06 p.m. Jan. 9, 2013 - Lawrence G. McMillan
Hedge funds are bullish on these stocks 11:57 a.m. Dec. 5, 2012 - Insider Monkey
Peregrine, FDA agree on brain-cancer drug study 11:56 a.m. Dec. 5, 2012 - MarketWatch.com
Drug trial contractors improve efficiency 10:24 a.m. Nov. 16, 2012 - MarketWatch.com
Monday’s biggest gaining and declining stocks 6:42 p.m. Sept. 25, 2012 - Greg Morcroft
Tuesday’s biggest gaining and declining stocks 5:09 p.m. Sept. 25, 2012 - Greg Morcroft
Peregrine Pharma down 86% after test data review 8:27 a.m. Sept. 24, 2012 - Steve Gelsi
Peregrine Pharma down 86% in premarket 8:18 a.m. Sept. 24, 2012 - Steve Gelsi
Peregrine reviewing Bavituximab results 7:42 a.m. Sept. 24, 2012 - Greg Morcroft
Some previous Bavituximab data not valid

eregrine 7:42 a.m. Sept. 24, 2012 - Greg Morcroft
Monday’s biggest gaining and declining stocks 2:42 p.m. Sept. 10, 2012 - MarketWatch
Regions Financial, Williams-Sonoma hit 52-week highs; Intel, Cisco active 11:11 a.m. Sept. 10, 2012 - blogs.marketwatch.com
Stocks to watch Monday: AIG, Michael Kors, Sears 6:41 a.m. Sept. 10, 2012 - MarketWatch
Peregrine rallies on bavituximab lung-cancer data 1:29 p.m. Sept. 7, 2012 - MarketWatch.com
Monday’s biggest gaining & declining stocks 2:53 p.m. Aug. 27, 2012 - MarketWatch
Peregrine Pharma slides 12% after negative report 2:21 p.m. Aug. 27, 2012 - Val Brickates Kennedy

Peregrine Pharmaceuticals (PPHM) Jumps: Stock Rises 10.7% - Tale of the Tape 9:39 a.m. Today - Zacks.com
Peregrine Pharmaceuticals' Q1 Loss Wider than Expected - Analyst Blog 9:00 a.m. Sept. 10, 2014 - Zacks.com
Peregrine Pharmaceuticals' (PPHM) CEO Steven King on Q1 2015 Results - Earnings Call Transcript 7:53 p.m. Sept. 9, 2014 - Seeking Alpha
10-Q: PEREGRINE PHARMACEUTICALS INC 4:29 p.m. Sept. 9, 2014 - Edgar Online - (EDG = 10Q, 10K)
Peregrine Pharmaceuticals (PPHM) Q1 2015 Results - Earnings Call Webcast 4:25 p.m. Sept. 9, 2014 - Seeking Alpha
Tekmira Pharmaceuticals Corp. Is More Than Just A Short-Term Trade 3:12 p.m. Aug. 27, 2014 - Seeking Alpha
Cel-Sci Is A Leader In The I-O Class Of Cancer Therapies 10:43 a.m. Aug. 12, 2014 - Seeking Alpha
Peregrine Pharmaceuticals' Q4 Loss Narrower than Expected - Analyst Blog 11:00 a.m. July 15, 2014 - Zacks.com
Peregrine Pharmaceuticals' (PPHM) CEO Steven King on Q4 2014 Results - Earnings Call Transcript 10:21 p.m. July 14, 2014 - Seeking Alpha
10-K: PEREGRINE PHARMACEUTICALS INC 5:00 p.m. July 14, 2014 - Edgar Online - (EDG = 10Q, 10K)
More on Peregrine fiscal Q4 and fiscal year results 4:26 p.m. July 14, 2014 - Seeking Alpha
Biotech Stock Mailbag: MannKind, Bluebird, Northwest Bio, More '14 Tradable Biotech Events 9:30 a.m. July 14, 2014 - TheStreet.com
First Week Of January 2015 Options Trading For Peregrine Pharmaceuticals (PPHM) 11:09 a.m. May 20, 2014 - TheStreet.com
Biotech Stock Mailbag: Sarepta, F-R Rule Stock Predictions, Merrimack 6:00 a.m. May 9, 2014 - TheStreet.com
Peregrine wins law suit 9:24 a.m. May 5, 2014 - Seeking Alpha
Medivation Signs Deal with OncoFusion Therapeutics - Analyst Blog 6:24 p.m. April 24, 2014 - Zacks.com
Interesting PPHM Call Options For June 21st 11:02 a.m. April 23, 2014 - TheStreet.com
Peregrine's Bavituximab has high success rate in animal testing 9:47 a.m. April 7, 2014 - Seeking Alpha
Peregrine Pharmaceuticals (PPHM) Shares March Higher, Can It Continue? - Tale of the Tape 8:39 a.m. March 18, 2014 - Zacks.com
Cel-Sci's Multikine - Potential 21st Century Superdrug 5:41 p.m. March 13, 2014 - Seeking Alpha

Data to Be Published in the Journal of Immunology Research Support Phosphatidylserine (PS) as a Potential Target in Ebola Infection 8:05 a.m. Oct. 15, 2014 - Marketwired
Data to Be Presented at CRI Immunotherapy Conference Show PS-Targeting Antibodies Enhance the Anti-Tumor Activity of Immune Checkpoint Inhibitors by Decreasing Levels of Myeloid Derived Suppressor Cells (MDSC) in the Tumor Microenvironment 8:03 a.m. Oct. 6, 2014 - Marketwire
Peregrine Pharmaceuticals Reports First Quarter Fiscal Year 2015 Financial Results and Recent Developments 4:01 p.m. Sept. 9, 2014 - Marketwire
Peregrine Pharmaceuticals Declares Quarterly Dividend on Its Series E Convertible Preferred Stock 4:00 p.m. Sept. 8, 2014 - Marketwire
Peregrine Pharmaceuticals to Report First Quarter Fiscal Year 2015 Financial Results After Market Close on September 9, 2014 4:01 p.m. Sept. 2, 2014 - Marketwire
Preclinical Data Presented at Annual Immunotherapies and Vaccine Summit Show That the Combination of Peregrine Pharmaceuticals' PS-Targeting Antibodies and Anti-PD-1 Antibodies Significantly Reduce Breast Cancer Progression 8:03 a.m. Aug. 11, 2014 - Marketwire
Small companies lead the I-O class of Cancer Therapies 8:03 a.m. Aug. 8, 2014 - ACCESSWIRE
Biotech Stocks Technical Data -- MannKind, ARIAD Pharma, Galena Biopharma, Geron, and Peregrine Pharma 9:00 a.m. Aug. 1, 2014 - PR Newswire - PRF
Peregrine Pharmaceuticals Reports Fourth Quarter and Year-End Fiscal Year 2014 Financial Results and Recent Developments 4:01 p.m. July 14, 2014 - Marketwire
Peregrine Pharmaceuticals to Report Fourth Quarter and Year-End Fiscal 2014 Financial Results After Market on July 14, 2014 4:00 p.m. July 7, 2014 - Marketwire
Technical Scrutiny on Biotech Stocks -- Research on Insmed, Peregrine Pharma, CytRx, and Celldex Therapeutics 6:40 a.m. June 30, 2014 - PR Newswire - PRF
Peregrine Pharmaceuticals Declares Quarterly Dividend on Its Series E Convertible Preferred Stock 4:00 p.m. June 10, 2014 - Marketwire
Pre-Market Review on Biotechnology Equities -- Research on BioMarin Pharma, Keryx Biopharma, Amgen, and Peregrine Pharma 8:30 a.m. May 30, 2014 - PR Newswire - PRF
Biotech Stocks Scanner -- Research on PDL BioPharma, Cytokinetics, Vical, and Peregrine Pharma 12:41 p.m. May 6, 2014 - PR Newswire - PRF
Peregrine Pharmaceuticals Announces Initiation of an Investigator-Sponsored Trial Combining Its Immunotherapy Bavituximab and Ipilimumab (Yervoy(R)) in Advanced Melanoma 7:31 a.m. April 23, 2014 - Marketwire
Healthcare Companies Report Results, Patents, and Stock Movements - Analyst Notes on Puma Biotechnology, Alnylam, INSYS Therapeutics, Peregrine Pharmaceuticals, and VIVUS 12:28 p.m. April 10, 2014 - PR Newswire - PRF
Data Presented at AACR Support Potential of Peregrine's PS-Targeting Immunotherapy Bavituximab to Enhance Anti-Tumor and Immune-Stimulating Effects of Anti-CTLA-4 and Anti-PD-1 Treatments in Models of Melanoma and Colon Cancer 11:01 a.m. April 9, 2014 - Marketwire
Morning Review on Top Gainers -- Research on Peregrine Pharma, Agios Pharma, Idenix Pharma, and Lexicon Pharma 1:15 p.m. April 8, 2014 - PR Newswire - PRF
Data Presented at AACR Support Potential of Combining Peregrine's PS-Targeting Immunotherapy Agent Bavituximab With Irradiation in Lung Cancer 8:04 a.m. April 7, 2014 - Marketwire
Peregrine Pharmaceuticals Announces Three Abstracts Accepted for Presentation at AACR 2014 Annual Meeting 4:01 p.m. April 1, 2014 - Marketwire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Texas Auto Insurance: Know Your Limits and Risks

Unpacking the Texas Auto Insurance Puzzle Ah, Texas. Land of vast highways and, apparently, some rather eyebrow-raising auto insurance complexities. Teri Cappadona from the Sapp Insurance Agency took to HelloNation to lay down the lowdown. If you're not up to speed, you might be blindsiding your bank account. We've all grumbled at those insurance bills, but understanding...

Furniture Quality: Expert Tips for Savvy Shoppers

Picking Apart Furniture Quality Before a Purchase In a world where cheap and flashy often overshadow durability, knowing what makes furniture stand the test of time isn't just wise—it's essential. Learn from Nate Bartlett, the furniture sage from Charlevoix, Michigan, who guides shoppers through the maze of quality indicators in a recent HelloNation article. If you're...

ServiceTitan Faces Investor Fury: Revenue Surprise

A Crippling Blow for ServiceTitan Investors When you're in the investing game long enough, you start to recognize the scent of trouble before it even hits the fan. In the case of ServiceTitan, Inc. (NASDAQ: TTAN), the smell came wafting in strong when the stock took a nosedive on September 9, 2026. Investors were left clutching their portfolios with bewilderment as shares...

Neuberger Fund Ups Distribution Amid Market Challenges

Neuberger Boosts Distribution: What's Driving This? I ain't about to sugarcoat it: the Neuberger Next Generation Connectivity Fund (NYSE: NBXG) decided to jack up its monthly distribution rate to $0.132 per share. This announcement, hitting wallets on November 30, 2026, has a record and ex-date of November 16. Now, that's a good ol' reliable payout for folks holding NBXG...

Bel-Mac and Seashore Unite for Gulf Coast Expansion

New Chapter for Bel-Mac and Seashore In a move that's got the local construction scene buzzing, Bel-Mac Roofing and Seashore Construction are tying the knot. It's more than just a merger; it's a power play to dominate Northwest Florida and the Gulf Coast with roofing and exterior construction services. The strategic investment from ACACIA Exterior Building Group sets the...

Radiofrequency Microneedling: A Fresh Skin Solution?

Vet the Process Before Diving In Everyone wants to turn back the clock on their skin, but it's crucial to know what you're getting into. This ain't a quick splash of water on the face; it's radiofrequency microneedling we're talking about. And honey, it’s no fairy tale—it’s science, plain and simple. Drilling Down on Microneedling This procedure, preached by Dr....

LakeSail Teams with Oxide for Robust AI Infrastructure

Talk about a match made for the tech-savvy folks who just can't wait to shatter the confines of the usual cloud service monopoly. In comes LakeSail, locking arms with Oxide Computer Company to offer something quite tantalizing: a chance for enterprises to handle AI workloads with the iron-fisted control they crave nowadays. Yeah, we're talking customer-owned...

LINC Shares Tumble Amid Misleading Growth Claims

When Promises Fall Short for Investors Look, the market's a tough beast, and Lincoln Educational Services (NASDAQ:LINC) just got stomped by it. From May through early August 2026, investors felt cozy with Lincoln's rosy pronouncements. Then, come August 10, Lincoln drops a dud: an abysmal 1% growth in student starts, tanking their share price by nearly a quarter. Yeah,...

University of Phoenix Leads Credentialing Dialogue at Summit

Credentials in the Spotlight at PESC Summit When you're talking credentials and data standards at the PESC Summit, you've got a gathering of big brains aiming to steer the wild ride of higher education into the future. This October, University of Phoenix leaders stepped up to the plate in Scottsdale, Arizona, delivering a frank talk about the role of credentials in...

Sonnenfeld, Curtis Shine in Honor of the Reiners' Legacy

Barry Sonnenfeld Takes Center Stage The spotlight is set for a different kind of blockbuster event—not on the silver screen this time, but under the starlit glamour of Beverly Hills. That's right, folks, Barry Sonnenfeld, the DGA and Emmy award-laden filmmaker we all know and love, will be the maestro hosting the Children's Institute's (CII) Cape & Gown Gala on November...